Trading Ideas Bristol-Myers Squibb Company Xetra

Equities

Real-time Estimate Tradegate Other stock markets 03:26:10 2024-06-28 am EDT			5-day change	1st Jan Change
38.94 ^EUR	-0.99%		+1.76%	-15.30%

Jun. 27	Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise	MT
Jun. 26	2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	MT

BRISTOL-MYERS SQUIBB COMPANY :The beginning of the move	19-09-18
BRISTOL-MYERS SQUIBB COMPANY :Underpinned by a support level	19-04-08
BRISTOL-MYERS SQUIBB COMPANY :Attractive price levels	16-09-26

No results for this search

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST